{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T21:16:45Z","timestamp":1770844605646,"version":"3.50.1"},"reference-count":192,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.intimp.2023.110439","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T03:01:43Z","timestamp":1686193303000},"page":"110439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["COVID-19 and severity of liver diseases: Possible crosstalk and clinical implications"],"prefix":"10.1016","volume":"121","author":[{"given":"Mohammad T.","family":"Imam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyad S.","family":"Almalki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah R.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed S.","family":"Al-Ghamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa H.","family":"Falemban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim M.","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naiyer","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munira","family":"Muhammad Alrooqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qaiser","family":"Jabeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9832-3224","authenticated-orcid":false,"given":"Imran","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2023.110439_b0005","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","volume":"5","author":"Zhang","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"20","key":"10.1016\/j.intimp.2023.110439_b0010","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.intimp.2023.110439_b0015","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00204-020-02734-1","article-title":"COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?","volume":"94","author":"Boeckmans","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110439_b0020","first-page":"348","article-title":"COVID-19 and liver disease: mechanistic and clinical perspectives, Nature reviews","volume":"18","author":"Marjot","year":"2021","journal-title":"Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110439_b0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/cld.974","article-title":"Chronic Liver Disease and COVID-19: Alcohol use disorder\/alcohol-associated liver disease, nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis, autoimmune liver disease, and compensated cirrhosis","volume":"15","author":"Kushner","year":"2020","journal-title":"Clin. Liver Dis."},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/00952990.2020.1753759","article-title":"What we can learn from COVID-19 outbreak in Iran about the importance of alcohol use education","volume":"46","author":"Shalbafan","year":"2020","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.intimp.2023.110439_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2020.102092","article-title":"Epidemic of COVID-19 in China and associated psychological problems","volume":"51","author":"Ahmed","year":"2020","journal-title":"Asian J. Psychiatr."},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0040","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/hep.31307","article-title":"Coronavirus disease 2019 hangover: A rising tide of alcohol use disorder and alcohol-associated liver disease","volume":"72","author":"Da","year":"2020","journal-title":"Hepatology (Baltimore Md.)"},{"issue":"1","key":"10.1016\/j.intimp.2023.110439_b0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/hep.31281","article-title":"Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD expert panel consensus statement","volume":"72","author":"Fix","year":"2020","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.intimp.2023.110439_b0050","article-title":"Covid-19: European drugs agency to review safety of ibuprofen","volume":"368","author":"Day","year":"2020","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.intimp.2023.110439_b0055","article-title":"Covid-19: ibuprofen can be used for symptoms, says UK agency, but reasons for change in advice are unclear","volume":"369","author":"Torjesen","year":"2020","journal-title":"BMJ (Clinical research ed.)"},{"issue":"9","key":"10.1016\/j.intimp.2023.110439_b0060","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1007\/s10620-022-07504-w","article-title":"Autoimmune hepatitis-like syndrome following COVID-19 vaccination: A systematic review of the literature","volume":"67","author":"Chow","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.intimp.2023.110439_b0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejim.2020.05.035","article-title":"Hepatic consequences of COVID-19 infection. Lapping or biting?","volume":"77","author":"Portincasa","year":"2020","journal-title":"Eur. J. Intern. Med."},{"issue":"4","key":"10.1016\/j.intimp.2023.110439_b0070","doi-asserted-by":"crossref","first-page":"ofac073","DOI":"10.1093\/ofid\/ofac073","article-title":"Association of nonalcoholic fatty liver disease with COVID-19 severity and pulmonary thrombosis: CovidFAT, a prospective, observational cohort study","volume":"9","author":"Vrsaljko","year":"2022","journal-title":"Open Forum Infect. Dis."},{"issue":"9","key":"10.1016\/j.intimp.2023.110439_b0075","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110439_b0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12072-022-10306-x","article-title":"Management of hepatitis B virus reactivation due to treatment of COVID-19","volume":"16","author":"Yip","year":"2022","journal-title":"Hep. Intl."},{"issue":"7","key":"10.1016\/j.intimp.2023.110439_b0085","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep4.1745","article-title":"Impact of COVID-19 in liver disease progression","volume":"5","author":"Martinez","year":"2021","journal-title":"Hepatology Commun."},{"issue":"5","key":"10.1016\/j.intimp.2023.110439_b0090","first-page":"998","article-title":"Liver injury during highly pathogenic human coronavirus infections, Liver international: official journal of the International Association for the Study of the","volume":"40","author":"Xu","year":"2020","journal-title":"Liver"},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0095","first-page":"229","article-title":"Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area","volume":"28","author":"Qian","year":"2020","journal-title":"Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chin. J. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110439_b0100","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jhep.2020.03.044","article-title":"Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study","volume":"73","author":"Ji","year":"2020","journal-title":"J. Hepatol."},{"issue":"1156","key":"10.1016\/j.intimp.2023.110439_b0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/postgradmedj-2020-138930","article-title":"COVID-19 associated variations in liver function parameters: a retrospective study","volume":"98","author":"Saini","year":"2022","journal-title":"Postgrad. Med. J."},{"issue":"2","key":"10.1016\/j.intimp.2023.110439_b0110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0002-9440(10)62989-6","article-title":"Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus","volume":"167","author":"Greenough","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"7807","key":"10.1016\/j.intimp.2023.110439_b0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.intimp.2023.110439_b0120","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ajem.2007.10.031","article-title":"The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome","volume":"26","author":"Wang","year":"2008","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.intimp.2023.110439_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100777","article-title":"A review on how to do hematology consults during COVID-19 pandemic","volume":"47","author":"Sahu","year":"2021","journal-title":"Blood Rev."},{"issue":"18","key":"10.1016\/j.intimp.2023.110439_b0130","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0135","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jhep.2020.04.006","article-title":"COVID-19: Abnormal liver function tests","volume":"73","author":"Cai","year":"2020","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110439_b0140","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1111\/all.14309","article-title":"COVID-19 in a designated infectious diseases hospital outside Hubei Province","volume":"75","author":"Cai","year":"2020","journal-title":"China, Allergy"},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0145","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/hep.31326","article-title":"Liver biochemistries in hospitalized patients with COVID-19","volume":"73","author":"Bloom","year":"2021","journal-title":"Hepatology (Baltimore Md.)"},{"issue":"10223","key":"10.1016\/j.intimp.2023.110439_b0150","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"10223","key":"10.1016\/j.intimp.2023.110439_b0155","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.intimp.2023.110439_b0160","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2023.110439_b0165","article-title":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series","volume":"368","author":"Xu","year":"2020","journal-title":"BMJ (Clinical research ed.)"},{"issue":"9","key":"10.1016\/j.intimp.2023.110439_b0170","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/CM9.0000000000000775","article-title":"Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease","volume":"133","author":"Liu","year":"2020","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"10.1016\/j.intimp.2023.110439_b0175","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/CM9.0000000000000824","article-title":"Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study","volume":"133","author":"Deng","year":"2020","journal-title":"Chin. Med. J. (Engl)"},{"issue":"10229","key":"10.1016\/j.intimp.2023.110439_b0180","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0185","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jhep.2020.04.006","article-title":"Characteristics of liver tests in COVID-19 patients","volume":"73","author":"Qingxian","year":"2020","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110439_b0190","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/path.1560","article-title":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways","volume":"203","author":"Ding","year":"2004","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110439_b0195","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/hep.20111","article-title":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases","volume":"39","author":"Chau","year":"2004","journal-title":"Hepatology (Baltimore Md.)"},{"key":"10.1016\/j.intimp.2023.110439_b0200","doi-asserted-by":"crossref","unstructured":"D.E. Gordon, G.M. Jang, M. Bouhaddou, J. Xu, K. Obernier, K.M. White, M.J. O'Meara, V.V. Rezelj, J.Z. Guo, D.L. Swaney, T.A. Tummino, R. H\u00fcttenhain, R.M. Kaake, A.L. Richards, B. Tutuncuoglu, H. Foussard, J. Batra, K. Haas, M. Modak, M. Kim, P. Haas, B.J. Polacco, H. Braberg, J.M. Fabius, M. Eckhardt, M. Soucheray, M.J. Bennett, M. Cakir, M.J. McGregor, Q. Li, B. Meyer, F. Roesch, T. Vallet, A. Mac Kain, L. Miorin, E. Moreno, Z.Z.C. Naing, Y. Zhou, S. Peng, Y. Shi, Z. Zhang, W. Shen, I.T. Kirby, J.E. Melnyk, J.S. Chorba, K. Lou, S.A. Dai, I. Barrio-Hernandez, D. Memon, C. Hernandez-Armenta, J. Lyu, C.J.P. Mathy, T. Perica, K.B. Pilla, S.J. Ganesan, D.J. Saltzberg, R. Rakesh, X. Liu, S.B. Rosenthal, L. Calviello, S. Venkataramanan, J. Liboy-Lugo, Y. Lin, X.P. Huang, Y. Liu, S.A. Wankowicz, M. Bohn, M. Safari, F.S. Ugur, C. Koh, N.S. Savar, Q.D. Tran, D. Shengjuler, S.J. Fletcher, M.C. O'Neal, Y. Cai, J.C.J. Chang, D.J. Broadhurst, S. Klippsten, P.P. Sharp, N.A. Wenzell, D. Kuzuoglu-Ozturk, H.Y. Wang, R. Trenker, J.M. Young, D.A. Cavero, J. Hiatt, T.L. Roth, U. Rathore, A. Subramanian, J. Noack, M. Hubert, R.M. Stroud, A.D. Frankel, O.S. Rosenberg, K.A. Verba, D.A. Agard, M. Ott, M. Emerman, N. Jura, M. von Zastrow, E. Verdin, A. Ashworth, O. Schwartz, C. d'Enfert, S. Mukherjee, M. Jacobson, H.S. Malik, D.G. Fujimori, T. Ideker, C.S. Craik, S.N. Floor, J.S. Fraser, J.D. Gross, A. Sali, B.L. Roth, D. Ruggero, J. Taunton, T. Kortemme, P. Beltrao, M. Vignuzzi, A. Garc\u00eda-Sastre, K.M. Shokat, B.K. Shoichet, N.J. Krogan, A SARS-CoV-2 protein interaction map reveals targets for drug repurposing, Nature 583(7816) (2020) 459-468.","DOI":"10.1038\/s41586-020-2286-9"},{"issue":"11","key":"10.1016\/j.intimp.2023.110439_b0205","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.mayocp.2020.09.005","article-title":"Clinical characteristics, diagnosis, and outcomes of 6 patients with COVID-19 infection and rhabdomyolysis","volume":"95","author":"Buckholz","year":"2020","journal-title":"Mayo Clin. Proc."},{"issue":"17","key":"10.1016\/j.intimp.2023.110439_b0210","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"48","key":"10.1016\/j.intimp.2023.110439_b0215","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.3748\/wjg.v26.i48.7693","article-title":"High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data","volume":"26","author":"D\u00edaz","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0220","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1111\/j.1750-2659.2011.00287.x","article-title":"Liver involvement during influenza infection: perspective on the 2009 influenza pandemic","volume":"6","author":"Papic","year":"2012","journal-title":"Influenza Other Respi. Viruses"},{"issue":"7","key":"10.1016\/j.intimp.2023.110439_b0225","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S2468-1253(20)30126-6","article-title":"Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis","volume":"5","author":"Mao","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110439_b0230","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/apt.15996","article-title":"Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients","volume":"52","author":"Ponziani","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2023.110439_b0235","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/gutjnl-2020-321726","article-title":"Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19","volume":"70","author":"Yip","year":"2021","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.intimp.2023.110439_b0240","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1136\/gutjnl-2020-323800","article-title":"Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study","volume":"70","author":"Weber","year":"2021","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.intimp.2023.110439_b0245","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jhep.2020.12.012","article-title":"Association of liver abnormalities with in-hospital mortality in patients with COVID-19","volume":"74","author":"Ding","year":"2021","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110439_b0250","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/liv.14455","article-title":"Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city","volume":"40","author":"Zhang","year":"2020","journal-title":"China, Liver Int.: official J. Int. Assoc. Study Liver"},{"issue":"4","key":"10.1016\/j.intimp.2023.110439_b0255","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/hep.31446","article-title":"Clinical features of patients infected with coronavirus disease 2019 With elevated liver biochemistries: A multicenter, retrospective study","volume":"73","author":"Fu","year":"2021","journal-title":"Hepatology (Baltimore Md.)"},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0260","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep.31404","article-title":"Acute liver injury in COVID-19: Prevalence and association with clinical outcomes in a large U.S. cohort","volume":"72","author":"Phipps","year":"2020","journal-title":"Hepatology (Baltimore Md.)"},{"issue":"4","key":"10.1016\/j.intimp.2023.110439_b0265","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/gutjnl-2020-322072","article-title":"Involvement of liver in COVID-19: systematic review and meta-analysis","volume":"70","author":"Yadav","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2023.110439_b0270","doi-asserted-by":"crossref","unstructured":"F. Lei, Y.M. Liu, F. Zhou, J.J. Qin, P. Zhang, L. Zhu, X.J. Zhang, J. Cai, L. Lin, S. Ouyang, X. Wang, C. Yang, X. Cheng, W. Liu, H. Li, J. Xie, B. Wu, H. Luo, F. Xiao, J. Chen, L. Tao, G. Cheng, Z.G. She, J. Zhou, H. Wang, J. Lin, P. Luo, S. Fu, J. Zhou, P. Ye, B. Xiao, W. Mao, L. Liu, Y. Yan, L. Liu, G. Chen, H. Li, X. Huang, B.H. Zhang, Y. Yuan, Longitudinal association between markers of liver injury and mortality in COVID-19 in China, Hepatology (Baltimore, Md.) 72(2) (2020) 389-398.","DOI":"10.1002\/hep.31301"},{"issue":"4","key":"10.1016\/j.intimp.2023.110439_b0275","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jhep.2020.05.035","article-title":"SARS-CoV-2: Is the liver merely a bystander to severe disease?","volume":"73","author":"Bangash","year":"2020","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110439_b0280","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jhep.2022.07.008","article-title":"Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper","volume":"77","author":"Marjot","year":"2022","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110439_b0285","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cld.967","article-title":"Interrelationship between coronavirus infection and liver disease","volume":"15","author":"Schaefer","year":"2020","journal-title":"Clin. Liver Dis."},{"issue":"6","key":"10.1016\/j.intimp.2023.110439_b0290","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/gutjnl-2020-320926","article-title":"Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms","volume":"69","author":"Jin","year":"2020","journal-title":"Gut"},{"issue":"19","key":"10.1016\/j.intimp.2023.110439_b0295","first-page":"1861","article-title":"Clinical characteristics of covid-19 in China","volume":"382","author":"Guan","year":"2020","journal-title":"Reply, New Engl. J. Med."},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0300","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jhep.2020.04.042","article-title":"Reply to: \u201cClinical characteristics of COVID-19 patients with abnormal liver tests\u201d","volume":"73","author":"Cai","year":"2020","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110439_b0305","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110439_b0310","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/JCMA.0000000000000319","article-title":"Gastrointestinal and liver manifestations in patients with COVID-19","volume":"83","author":"Lee","year":"2020","journal-title":"J. Chinese Med. Assoc.: JCMA"},{"issue":"1","key":"10.1016\/j.intimp.2023.110439_b0315","doi-asserted-by":"crossref","first-page":"18","DOI":"10.14218\/JCTH.2020.00018","article-title":"COVID-19 and liver dysfunction: Current insights and emergent therapeutic strategies","volume":"8","author":"Feng","year":"2020","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110439_b0320","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.cgh.2020.04.002","article-title":"Clinical features of COVID-19-related liver functional abnormality","volume":"18","author":"Fan","year":"2020","journal-title":"Clinical Gastroenterol. Hepatol.: Official Clin. Pract. J. Am. Gastroenterol. Assoc."},{"issue":"2","key":"10.1016\/j.intimp.2023.110439_b0325","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2020.04.045","article-title":"Prevalence and characteristics of gastrointestinal symptoms in patients with severe acute respiratory syndrome coronavirus 2 infection in the United States: A multicenter cohort study","volume":"159","author":"Redd","year":"2020","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0330","first-page":"103","article-title":"Liver biochemistry during the course of influenza A\/H1N1 infection","volume":"6","author":"Seretis","year":"2013","journal-title":"Gastroenterol. Res."},{"issue":"20","key":"10.1016\/j.intimp.2023.110439_b0335","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1056\/NEJMoa030666","article-title":"A cluster of cases of severe acute respiratory syndrome in Hong Kong","volume":"348","author":"Tsang","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.intimp.2023.110439_b0340","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1056\/NEJM200004273421707","article-title":"Evaluation of abnormal liver-enzyme results in asymptomatic patients","volume":"342","author":"Pratt","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.intimp.2023.110439_b0345","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1053\/j.gastro.2020.02.054","article-title":"COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission","volume":"158","author":"Gu","year":"2020","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.intimp.2023.110439_b0350","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nrmicro3143","article-title":"A decade after SARS: strategies for controlling emerging coronaviruses","volume":"11","author":"Graham","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110439_b0355","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.intimp.2023.110439_b0360","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110439_b0365","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/hep.27406","article-title":"The global burden of liver disease: the major impact of China","volume":"60","author":"Wang","year":"2014","journal-title":"Hepatology (Baltimore Md.)"},{"issue":"1","key":"10.1016\/j.intimp.2023.110439_b0370","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0375","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2023.110439_b0380","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/aje\/kws448","article-title":"Prevalence of nonalcoholic fatty liver disease in the United States: the third national health and nutrition examination survey, 1988\u20131994","volume":"178","author":"Lazo","year":"2013","journal-title":"Am. J. Epidemiol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110439_b0385","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","author":"Younossi","year":"2011","journal-title":"Clin. Gastroenterol. Hepatol.: Official Clin. Pract. J. Am. Gastroenterol. Assoc."},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0390","article-title":"Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper","volume":"2","author":"Boettler","year":"2020","journal-title":"JHEP Rep.: Innovat. Hepatol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110439_b0395","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1136\/gut.2004.062398","article-title":"Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2","volume":"54","author":"Paizis","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2023.110439_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154244","article-title":"Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease","volume":"108","author":"Zheng","year":"2020","journal-title":"Metab. Clin. Exp."},{"issue":"9","key":"10.1016\/j.intimp.2023.110439_b0405","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cgh.2011.02.031","article-title":"Immune dysfunction and infections in patients with cirrhosis","volume":"9","author":"Bonnel","year":"2011","journal-title":"Clin. Gastroenterol. Hepatology: Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"issue":"2","key":"10.1016\/j.intimp.2023.110439_b0410","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jhep.2020.04.005","article-title":"The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care","volume":"73","author":"Tapper","year":"2020","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110439_b0415","first-page":"1316","article-title":"Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis, Liver international : official journal of the International Association for the Study of the","volume":"40","author":"Mantovani","year":"2020","journal-title":"Liver"},{"issue":"11","key":"10.1016\/j.intimp.2023.110439_b0420","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrgastro.2015.172","article-title":"Keys to long-term care of the liver transplant recipient","volume":"12","author":"Watt","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110439_b0425","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/hep.26426","article-title":"Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients","volume":"58","author":"Ben\u00edtez","year":"2013","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1016\/j.intimp.2023.110439_b0430","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2020.07.040","article-title":"Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients","volume":"74","author":"Colmenero","year":"2021","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110439_b0435","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/ajt.16247","article-title":"SARS-CoV-2 infection and early mortality of waitlisted and solid organ transplant recipients in England: A national cohort study","volume":"20","author":"Ravanan","year":"2020","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"11","key":"10.1016\/j.intimp.2023.110439_b0440","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S2468-1253(20)30271-5","article-title":"Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study","volume":"5","author":"Webb","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110439_b0445","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.transproceed.2020.11.009","article-title":"SARS-CoV-2 seroprevalence and clinical features of COVID-19 in a German liver transplant recipient cohort: A prospective serosurvey study","volume":"53","author":"Rauber","year":"2021","journal-title":"Transpl. Proc."},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0450","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2020.05.050","article-title":"COVID-19 in liver transplant recipients: An initial experience from the US epicenter","volume":"159","author":"Lee","year":"2020","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.intimp.2023.110439_b0455","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/ajt.15941","article-title":"COVID-19 in solid organ transplant recipients: Initial report from the US epicenter","volume":"20","author":"Pereira","year":"2020","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"7","key":"10.1016\/j.intimp.2023.110439_b0460","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/j.1600-6143.2011.03498.x","article-title":"Sex-based disparities in liver transplant rates in the United States","volume":"11","author":"Mathur","year":"2011","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"11","key":"10.1016\/j.intimp.2023.110439_b0465","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1111\/j.1600-6143.2011.03703.x","article-title":"Impact of MELD-based allocation on end-stage renal disease after liver transplantation","volume":"11","author":"Sharma","year":"2011","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"6","key":"10.1016\/j.intimp.2023.110439_b0470","doi-asserted-by":"crossref","first-page":"e13554","DOI":"10.1111\/ctr.13554","article-title":"The impact of post-transplant diabetes mellitus on liver transplant outcomes","volume":"33","author":"Lieber","year":"2019","journal-title":"Clin. Transplant."},{"issue":"4","key":"10.1016\/j.intimp.2023.110439_b0475","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/lt.500040402","article-title":"Weight change and obesity after liver transplantation: incidence and risk factors","volume":"4","author":"Everhart","year":"1998","journal-title":"Liver Transplant. Surg.: Off. Publicat. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"issue":"2","key":"10.1016\/j.intimp.2023.110439_b0480","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1053\/j.gastro.2015.10.043","article-title":"Aging of liver transplant registrants and recipients: trends and impact on waitlist outcomes, post-transplantation outcomes, and transplant-related survival benefit","volume":"150","author":"Su","year":"2016","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.intimp.2023.110439_b0485","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/lt.21060","article-title":"Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence","volume":"13","author":"Seyam","year":"2007","journal-title":"Liver Transplant. Surg.: Off. Publicat. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"issue":"6","key":"10.1016\/j.intimp.2023.110439_b0490","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/hep.31574","article-title":"Liver Injury in liver transplant recipients with coronavirus disease 2019 (COVID-19): U.S. multicenter experience","volume":"72","author":"Rabiee","year":"2020","journal-title":"Hepatology (Baltimore Md.)"},{"key":"10.1016\/j.intimp.2023.110439_b0495","article-title":"Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study","volume":"371","author":"Clift","year":"2020","journal-title":"BMJ (Clinical research ed.)"},{"issue":"10","key":"10.1016\/j.intimp.2023.110439_b0500","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2023.110439_b0505","unstructured":"Q. Zhang, P. Bastard, Z. Liu, J. Le Pen, M. Moncada-Velez, J. Chen, M. Ogishi, I.K.D. Sabli, S. Hodeib, C. Korol, J. Rosain, K. Bilguvar, J. Ye, A. Bolze, B. Bigio, R. Yang, A.A. Arias, Q. Zhou, Y. Zhang, F. Onodi, S. Korniotis, L. Karpf, Q. Philippot, M. Chbihi, L. Bonnet-Madin, K. Dorgham, N. Smith, W.M. Schneider, B.S. Razooky, H.H. Hoffmann, E. Michailidis, L. Moens, J.E. Han, L. Lorenzo, L. Bizien, P. Meade, A.L. Neehus, A.C. Ugurbil, A. Corneau, G. Kerner, P. Zhang, F. Rapaport, Y. Seeleuthner, J. Manry, C. Masson, Y. Schmitt, A. Schl\u00fcter, T. Le Voyer, T. Khan, J. Li, J. Fellay, L. Roussel, M. Shahrooei, M.F. Alosaimi, D. Mansouri, H. Al-Saud, F. Al-Mulla, F. Almourfi, S.Z. Al-Muhsen, F. Alsohime, S. Al Turki, R. Hasanato, D. van de Beek, A. Biondi, L.R. Bettini, M. D'Angio, P. Bonfanti, L. Imberti, A. Sottini, S. Paghera, E. Quiros-Roldan, C. Rossi, A.J. Oler, M.F. Tompkins, C. Alba, I. Vandernoot, J.C. Goffard, G. Smits, I. Migeotte, F. Haerynck, P. Soler-Palacin, A. Martin-Nalda, R. Colobran, P.E. Morange, S. Keles, F. \u00c7\u00f6lkesen, T. Ozcelik, K.K. Yasar, S. Senoglu, N. Karabela \u015e, C. Rodr\u00edguez-Gallego, G. Novelli, S. Hraiech, Y. Tandjaoui-Lambiotte, X. Duval, C. Laou\u00e9nan, A.L. Snow, C.L. Dalgard, J.D. Milner, D.C. Vinh, T.H. Mogensen, N. Marr, A.N. Spaan, B. Boisson, S. Boisson-Dupuis, J. Bustamante, A. Puel, M.J. Ciancanelli, I. Meyts, T. Maniatis, V. Soumelis, A. Amara, M. Nussenzweig, A. Garc\u00eda-Sastre, F. Krammer, A. Pujol, D. Duffy, R.P. Lifton, S.Y. Zhang, G. Gorochov, V. B\u00e9ziat, E. Jouanguy, V. Sancho-Shimizu, C.M. Rice, L. Abel, L.D. Notarangelo, A. Cobat, H.C. Su, J.L. Casanova, Inborn errors of type I IFN immunity in patients with life-threatening COVID-19, Science (New York, N.Y.) 370(6515) (2020) 1-14."},{"key":"10.1016\/j.intimp.2023.110439_b0510","unstructured":"P. Bastard, L.B. Rosen, Q. Zhang, E. Michailidis, H.H. Hoffmann, Y. Zhang, K. Dorgham, Q. Philippot, J. Rosain, V. B\u00e9ziat, J. Manry, E. Shaw, L. Haljasm\u00e4gi, P. Peterson, L. Lorenzo, L. Bizien, S. Trouillet-Assant, K. Dobbs, A.A. de Jesus, A. Belot, A. Kallaste, E. Catherinot, Y. Tandjaoui-Lambiotte, J. Le Pen, G. Kerner, B. Bigio, Y. Seeleuthner, R. Yang, A. Bolze, A.N. Spaan, O.M. Delmonte, M.S. Abers, A. Aiuti, G. Casari, V. Lampasona, L. Piemonti, F. Ciceri, K. Bilguvar, R.P. Lifton, M. Vasse, D.M. Smadja, M. Migaud, J. Hadjadj, B. Terrier, D. Duffy, L. Quintana-Murci, D. van de Beek, L. Roussel, D.C. Vinh, S.G. Tangye, F. Haerynck, D. Dalmau, J. Martinez-Picado, P. Brodin, M.C. Nussenzweig, S. Boisson-Dupuis, C. Rodr\u00edguez-Gallego, G. Vogt, T.H. Mogensen, A.J. Oler, J. Gu, P.D. Burbelo, J.I. Cohen, A. Biondi, L.R. Bettini, M. D'Angio, P. Bonfanti, P. Rossignol, J. Mayaux, F. Rieux-Laucat, E.S. Husebye, F. Fusco, M.V. Ursini, L. Imberti, A. Sottini, S. Paghera, E. Quiros-Roldan, C. Rossi, R. Castagnoli, D. Montagna, A. Licari, G.L. Marseglia, X. Duval, J. Ghosn, J.S. Tsang, R. Goldbach-Mansky, K. Kisand, M.S. Lionakis, A. Puel, S.Y. Zhang, S.M. Holland, G. Gorochov, E. Jouanguy, C.M. Rice, A. Cobat, L.D. Notarangelo, L. Abel, H.C. Su, J.L. Casanova, Autoantibodies against type I IFNs in patients with life-threatening COVID-19, Science (New York, N.Y.) 370(6515) (2020) 1-13."},{"issue":"8","key":"10.1016\/j.intimp.2023.110439_b0515","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.intimp.2023.110439_b0520","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/lt.25806","article-title":"Coronaviruses and immunosuppressed patients: the facts during the third epidemic","volume":"26","author":"Merli","year":"2020","journal-title":"Liver Trans.: Off. Publicat. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"issue":"5","key":"10.1016\/j.intimp.2023.110439_b0525","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/annrheumdis-2020-217424","article-title":"Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies","volume":"79","author":"Monti","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2023.110439_b0530","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2020.04.002","article-title":"Management of patients with autoimmune liver disease during COVID-19 pandemic","volume":"73","author":"Lleo","year":"2020","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110439_b0535","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/cld.972","article-title":"Synthesis of liver associations recommendations for hepatology and liver transplant care during the COVID-19 pandemic","volume":"15","author":"Lau","year":"2020","journal-title":"Clin. Liver Dis."},{"issue":"5","key":"10.1016\/j.intimp.2023.110439_b0540","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/cld.970","article-title":"SARS-CoV-2 and the Liver: Considerations in hepatitis B and hepatitis C infections","volume":"15","author":"Reddy","year":"2020","journal-title":"Clin. Liver Dis."},{"issue":"9","key":"10.1016\/j.intimp.2023.110439_b0545","doi-asserted-by":"crossref","first-page":"416","DOI":"10.5694\/mja2.50577","article-title":"Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19)","volume":"212","author":"Zha","year":"2020","journal-title":"Med. J. Aust."},{"issue":"5","key":"10.1016\/j.intimp.2023.110439_b0550","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1016\/S2352-3018(20)30111-9","article-title":"COVID-19 in patients with HIV: clinical case series","volume":"7","author":"Blanco","year":"2020","journal-title":"The lancet. HIV"},{"issue":"6","key":"10.1016\/j.intimp.2023.110439_b0555","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/jmv.25732","article-title":"Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city China","volume":"92","author":"Zhu","year":"2020","journal-title":"J. Med. Virol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110439_b0560","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1002\/jmv.25955","article-title":"HIV\/SARS-CoV-2 coinfected patients in Istanbul, Turkey","volume":"92","author":"Altuntas Aydin","year":"2020","journal-title":"J. Med. Virol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110439_b0565","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/jmv.25879","article-title":"Computed tomography imaging of an HIV-infected patient with coronavirus disease 2019","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"issue":"16","key":"10.1016\/j.intimp.2023.110439_b0570","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1093\/cid\/ciaa408","article-title":"Early virus clearance and delayed antibody response in a case of coronavirus disease 2019 (COVID-19) with a history of coinfection with human immunodeficiency virus type 1 and hepatitis C virus","volume":"71","author":"Zhao","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2023.110439_b0575","first-page":"133","article-title":"COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response","volume":"11","author":"Farhoudian","year":"2020","journal-title":"Int. Soc. Addict. Med. Pract. Policy Interest Group Position Paper, Basic and Clin. Neurosci"},{"issue":"1","key":"10.1016\/j.intimp.2023.110439_b0580","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.gastro.2014.10.039","article-title":"American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy","volume":"148","author":"Reddy","year":"2015","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.intimp.2023.110439_b0585","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/1756-185X.13010","article-title":"Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation","volume":"20","author":"Chen","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2023.110439_b0590","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5144\/0256-4947.2020.273","article-title":"Principles of care for patients with liver disease during the coronavirus disease 2019 (COVID-19) pandemic: Position statement of the saudi association for the study of liver disease and transplantation","volume":"40","author":"Alqahtani","year":"2020","journal-title":"Ann. Saudi Med."},{"issue":"5","key":"10.1016\/j.intimp.2023.110439_b0595","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/cld.968","article-title":"COVID 19: Management of decompensated cirrhosis and liver transplant recipients","volume":"15","author":"Rosenblatt","year":"2020","journal-title":"Clin. Liver Dis."},{"issue":"16","key":"10.1016\/j.intimp.2023.110439_b0600","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jama.2020.4326","article-title":"Characteristics and outcomes of 21 critically Ill patients with COVID-19 in Washington state","volume":"323","author":"Arentz","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.intimp.2023.110439_b0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2010.09.010","article-title":"Cardiovascular diseases and the liver","volume":"15","author":"Weisberg","year":"2011","journal-title":"Clin. Liver Dis."},{"issue":"1","key":"10.1016\/j.intimp.2023.110439_b0610","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cardfail.2009.08.002","article-title":"Abnormal liver function in relation to hemodynamic profile in heart failure patients","volume":"16","author":"van Deursen","year":"2010","journal-title":"J. Card. Fail."},{"issue":"12","key":"10.1016\/j.intimp.2023.110439_b0615","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.amjmed.2015.07.033","article-title":"the incidence and outcomes of ischemic hepatitis: A systematic review with meta-analysis","volume":"128","author":"Tapper","year":"2015","journal-title":"Am. J. Med."},{"key":"10.1016\/j.intimp.2023.110439_b0620","doi-asserted-by":"crossref","unstructured":"M. Fuchs, A.J. Sanyal, Sepsis and cholestasis, Clinics in liver disease 12(1) (2008) 151-72, ix.","DOI":"10.1016\/j.cld.2007.11.002"},{"issue":"24","key":"10.1016\/j.intimp.2023.110439_b0625","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2023.110439_b0630","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"5","key":"10.1016\/j.intimp.2023.110439_b0635","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/0960327115595684","article-title":"Establishment of a new animal model of azithromycin-induced liver injury and study the molecular pathological change during the process","volume":"35","author":"Li","year":"2016","journal-title":"Hum. Exp. Toxicol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110439_b0640","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.qai.0000219774.20174.64","article-title":"Lopinavir\/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers","volume":"42","author":"Yeh","year":"2006","journal-title":"J. Acquired Immune Deficiency Syndr. (1999)"},{"issue":"6","key":"10.1016\/j.intimp.2023.110439_b0645","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/0961203314561667","article-title":"Hydroxychloroquine-induced toxic hepatitis in a patient with systemic lupus erythematosus: a case report","volume":"24","author":"Abdel Galil","year":"2015","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.intimp.2023.110439_b0650","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1124\/dmd.119.089557","article-title":"Acetaminophen-induced liver injury alters expression and activities of cytochrome P450 enzymes in an age-dependent manner in mouse liver","volume":"48","author":"Bao","year":"2020","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.intimp.2023.110439_b0655","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gut.35.4.569","article-title":"Fulminant hepatic failure secondary to hydroxychloroquine","volume":"35","author":"Makin","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2023.110439_b0660","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discovery"},{"issue":"2","key":"10.1016\/j.intimp.2023.110439_b0665","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cgh.2014.07.054","article-title":"Clinical and histologic features of azithromycin-induced liver injury","volume":"13","author":"Martinez","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol.: Off. Clin.Pract. J. Am. Gastroenterol. Assoc."},{"key":"10.1016\/j.intimp.2023.110439_b0670","doi-asserted-by":"crossref","unstructured":"G.A. FitzGerald, Misguided drug advice for COVID-19, Science (New York, N.Y.) 367(6485) (2020) 1434.","DOI":"10.1126\/science.abb8034"},{"issue":"2","key":"10.1016\/j.intimp.2023.110439_b0675","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9020575","article-title":"Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China","volume":"9","author":"Deng","year":"2020","journal-title":"J. Clin. Med."},{"issue":"8","key":"10.1016\/j.intimp.2023.110439_b0680","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2016.01.025","article-title":"Inflammation in alcoholic and nonalcoholic fatty liver disease: Friend or foe?","volume":"150","author":"Gao","year":"2016","journal-title":"Gastroenterology"},{"issue":"27","key":"10.1016\/j.intimp.2023.110439_b0685","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"10269","key":"10.1016\/j.intimp.2023.110439_b0690","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.intimp.2023.110439_b0695","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"10275","key":"10.1016\/j.intimp.2023.110439_b0700","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0705","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S2468-1253(21)00008-X","article-title":"SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question","volume":"6","author":"Marjot","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2023.110439_b0710","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ebiom.2019.10.011","article-title":"CD8(+)T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction","volume":"49","author":"Leboss\u00e9","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2023.110439_b0715","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ebiom.2019.10.056","article-title":"Cirrhosis-associated immune dysfunction: Novel insights in impaired adaptive immunity","volume":"50","author":"Liaskou","year":"2019","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.intimp.2023.110439_b0720","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1086\/315245","article-title":"Pneumococcal vaccine response in cirrhosis and liver transplantation","volume":"181","author":"McCashland","year":"2000","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.intimp.2023.110439_b0725","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1942","article-title":"Response to hepatitis B vaccination in patients with liver cirrhosis","volume":"27","author":"Aggeletopoulou","year":"2017","journal-title":"Rev. Med. Virol."},{"issue":"8","key":"10.1016\/j.intimp.2023.110439_b0730","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.clinthera.2017.07.005","article-title":"A Comprehensive Review of Immunization Practices in Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients","volume":"39","author":"Chong","year":"2017","journal-title":"Clin. Ther."},{"key":"10.1016\/j.intimp.2023.110439_b0735","doi-asserted-by":"crossref","unstructured":"G. Garcia-Tsao, J.G. Abraldes, A. Berzigotti, J. Bosch, Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases, Hepatology (Baltimore, Md.) 65(1) (2017) 310-335.","DOI":"10.1002\/hep.28906"},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0740","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jhep.2020.09.024","article-title":"Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study","volume":"74","author":"Marjot","year":"2021","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110439_b0745","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jhep.2021.01.021","article-title":"SARS-CoV-2 infection in patients with autoimmune hepatitis","volume":"74","author":"Marjot","year":"2021","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110439_b0750","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1074248420958973","article-title":"COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism\/Prophylactic and Therapeutic Management","volume":"26","author":"Manolis","year":"2021","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"23","key":"10.1016\/j.intimp.2023.110439_b0755","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110439_b0760","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1053\/j.gastro.2017.04.042","article-title":"Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis","volume":"153","author":"Loffredo","year":"2017","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.intimp.2023.110439_b0765","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1111\/jth.15094","article-title":"Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration","volume":"18","author":"Tritschler","year":"2020","journal-title":"Journal of thrombosis and haemostasis : JTH"},{"key":"10.1016\/j.intimp.2023.110439_b0770","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.thromres.2020.09.026","article-title":"Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)","volume":"196","author":"Lemos","year":"2020","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.110439_b0775","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/liv.14247","article-title":"The health impact of delaying direct-acting antiviral treatment for chronic hepatitis C: A decision-analytic approach","volume":"40","author":"Erman","year":"2020","journal-title":"Liver Int.: Off. J. Int. Assoc. Study Liver"},{"issue":"4","key":"10.1016\/j.intimp.2023.110439_b0780","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/gutjnl-2014-308786","article-title":"Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: a nationwide cohort study","volume":"65","author":"Wu","year":"2016","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.intimp.2023.110439_b0785","article-title":"Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area","volume":"3","author":"Amaddeo","year":"2021","journal-title":"JHEP Rep.: Innovat. Hepatol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110439_b0790","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41575-020-0347-z","article-title":"COVID-19 and liver transplantation","volume":"17","author":"Di Maira","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110439_b0795","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/hep4.1620","article-title":"The Impact of COVID-19 on Organ Donation, Procurement, and Liver Transplantation in the United States","volume":"5","author":"Merola","year":"2021","journal-title":"Hepatol. Commun."},{"issue":"7","key":"10.1016\/j.intimp.2023.110439_b0800","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/ajt.15933","article-title":"Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approach","volume":"20","author":"Ritschl","year":"2020","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"1","key":"10.1016\/j.intimp.2023.110439_b0805","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S2468-1253(20)30360-5","article-title":"Resuming liver transplantation amid the COVID-19 pandemic","volume":"6","author":"Thorburn","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2023.110439_b0810","doi-asserted-by":"crossref","unstructured":"E.C. Verna, M. Serper, J. Chu, K. Corey, O.K. Fix, K. Hoyt, K.A. Page, R. Loomba, M. Li, G.T. Everson, M.W. Fried, G. Garcia-Tsao, N. Terrault, A.S. Lok, R.T. Chung, K.R. Reddy, Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation, Hepatology (Baltimore, Md.) 72(5) (2020) 1819-1837.","DOI":"10.1002\/hep.31491"},{"key":"10.1016\/j.intimp.2023.110439_b0815","doi-asserted-by":"crossref","unstructured":"I. Shahid A.R. Alzahrani S.S. Al-Ghamdi I.M. Alanazi S. Rehman S. Hassan Hepatitis C Diagnosis: Simplified Solutions, Predictive Barriers, and Future Promises, Diagnostics 11 2021 (Basel, Switzerland).","DOI":"10.3390\/diagnostics11071253"},{"key":"10.1016\/j.intimp.2023.110439_b0820","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijsu.2020.04.018","article-title":"The socio-economic implications of the coronavirus pandemic (COVID-19): A review","volume":"78","author":"Nicola","year":"2020","journal-title":"Int. J. Surgery (London, England)"},{"issue":"7","key":"10.1016\/j.intimp.2023.110439_b0825","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41433-020-0944-7","article-title":"Impact of the COVID-19 lockdown on basic science research in ophthalmology: the experience of a highly specialized research facility in France","volume":"34","author":"Nassisi","year":"2020","journal-title":"Eye (Lond.)"},{"issue":"1","key":"10.1016\/j.intimp.2023.110439_b0830","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2020.07.042","article-title":"Impact of COVID-19 on global HCV elimination efforts","volume":"74","author":"Blach","year":"2021","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110439_b0835","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S2468-1253(20)30237-5","article-title":"Eliminating viral hepatitis in the COVID-19 era: weighing challenge and opportunity","volume":"5","author":"Hepatology","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0840","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jhep.2020.05.022","article-title":"A local response to COVID-19 for advanced liver disease: Current model of care, challenges and opportunities","volume":"73","author":"Serper","year":"2020","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0845","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/jech-2020-215060","article-title":"Mental health and health behaviours before and during the initial phase of the COVID-19 lockdown: longitudinal analyses of the UK Household Longitudinal Study","volume":"75","author":"Niedzwiedz","year":"2021","journal-title":"J. Epidemiol. Community Health"},{"issue":"10","key":"10.1016\/j.intimp.2023.110439_b0850","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S2468-1253(20)30251-X","article-title":"Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder","volume":"5","author":"Kim","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110439_b0855","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/flgastro-2020-101693","article-title":"Severe alcohol-related liver disease admissions post-COVID-19 lockdown: canary in the coal mine?","volume":"12","author":"Cargill","year":"2021","journal-title":"Frontline Gastroenterol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110439_b0860","doi-asserted-by":"crossref","DOI":"10.3390\/nu12072016","article-title":"Changes in weight and nutritional habits in adults with obesity during the \u201clockdown\u201d period caused by the COVID-19 virus emergency","volume":"12","author":"Pellegrini","year":"2020","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0865","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1053\/j.gastro.2020.05.005","article-title":"Declining Cirrhosis Hospitalizations in the Wake of the COVID-19 Pandemic: A National Cohort Study","volume":"159","author":"Mahmud","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.intimp.2023.110439_b0870","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jhep.2022.07.028","article-title":"Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States","volume":"78","author":"Gao","year":"2022","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110439_b0875","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3350\/cmh.2020.0126","article-title":"Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea","volume":"26","author":"Lee","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"issue":"8","key":"10.1016\/j.intimp.2023.110439_b0880","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/hep4.1957","article-title":"Interaction of metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease with advanced fibrosis in the death and intubation of patients hospitalized with coronavirus disease 2019","volume":"6","author":"V\u00e1zquez-Medina","year":"2022","journal-title":"Hepatol. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2023.110439_b0885","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12072-020-10123-0","article-title":"Implications of liver injury in risk-stratification and management of patients with COVID-19","volume":"15","author":"Shao","year":"2021","journal-title":"Hep. Intl."},{"issue":"2","key":"10.1016\/j.intimp.2023.110439_b0890","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1053\/j.gastro.2020.04.064","article-title":"Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the United States: A multicenter research network study","volume":"159","author":"Singh","year":"2020","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0895","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2020.05.013","article-title":"High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry","volume":"73","author":"Moon","year":"2020","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110439_b0900","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1053\/j.gastro.2021.07.010","article-title":"Outcomes of SARS-CoV-2 infection in patients with chronic liver disease and cirrhosis: A national COVID cohort collaborative study","volume":"161","author":"Ge","year":"2021","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.intimp.2023.110439_b0905","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S2468-1253(20)30116-3","article-title":"COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy","volume":"5","author":"Bhoori","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110439_b0910","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1111\/ajt.16280","article-title":"Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States","volume":"20","author":"Molnar","year":"2020","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"10","key":"10.1016\/j.intimp.2023.110439_b0915","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/tri.13680","article-title":"Impact of COVID-19 on liver transplantation in Europe: alert from an early survey of European liver and intestine transplantation association and European liver transplant registry","volume":"33","author":"Polak","year":"2020","journal-title":"Transplant Int. Off. J. Euro. Soc. Organ Transplant."},{"issue":"1","key":"10.1016\/j.intimp.2023.110439_b0920","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/07853890.2022.2034936","article-title":"Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19:a meta-analysis","volume":"54","author":"Wen","year":"2022","journal-title":"Ann. Med."},{"key":"10.1016\/j.intimp.2023.110439_b0925","unstructured":"Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19; https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19\/, 2021 (accessed 5 May 2023)."},{"key":"10.1016\/j.intimp.2023.110439_b0930","unstructured":"Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults; https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-additional-oral-antiviral-treatment-covid-19\/, 2021 (accessed 6 May 2023)."},{"key":"10.1016\/j.intimp.2023.110439_b0935","year":"2022","journal-title":"Molnupiravir."},{"key":"10.1016\/j.intimp.2023.110439_b0940","unstructured":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Paxlovid. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK577815\/, 2022 (accessed 8 May 2023)."},{"issue":"3","key":"10.1016\/j.intimp.2023.110439_b0945","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ajg.2022.04.005","article-title":"Sofosbuvir\/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection: A randomized controlled trial for repurposing antivirals","volume":"23","author":"Medhat","year":"2022","journal-title":"Arab J. Gastroenterol.: Off. Publicat. Pan-Arab Assoc. Gastroenterol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110439_b0950","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s13337-021-00691-6","article-title":"Direct acting anti-hepatitis C combinations as potential COVID-19 protease inhibitors","volume":"32","author":"Hamed","year":"2021","journal-title":"Virusdisease"},{"key":"10.1016\/j.intimp.2023.110439_b0955","unstructured":"The Pitfalls and Promise of Using Repurposed Drugs for COVID-19 https:\/\/www.medscape.com\/viewarticle\/952037\/, 2021 (accessed 10 May 2023)."},{"key":"10.1016\/j.intimp.2023.110439_b0960","unstructured":"Hepatitis C Antivirals May Fight SARS-CoV-2; https:\/\/www.medscape.com\/viewarticle\/953902\/, 2021 (accessed 11 May 2023)."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923007622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923007622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:13:16Z","timestamp":1761588796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923007622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":192,"alternative-id":["S1567576923007622"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110439","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and severity of liver diseases: Possible crosstalk and clinical implications","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110439"}}